ArticleAdvanced biomedical research2024
Antimicrobial Resistance Pattern, Predisposing Factors, and Outcome of Serratia Infection in Patients Treated at a Secondary-Care Hospital in Oman: A 5-Year Retrospective Study.
Article in Advanced biomedical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Review
- From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026Review
- Epidemiological surveillance and risk stratification of diarrhoeagenic bacterial pathogens: a multi-centre hospital study in Lagos, Nigeria.Tropical diseases, travel medicine and vaccines · 2026Article
- Characterization and complete genomic sequence of a novel phage BUCT805 infectingMicrobiology spectrum · 2026Article
- Clinical and Genomic Characterization of Serratia Bloodstream Infections.CMI communications · 2025Article
- Epidemiology, resistance profiles, and risk factors of multidrug- and carbapenem-resistant Serratia marcescens infections: a retrospective study of 242 cases.BMC infectious diseases · 2025Article
- Serratia marcescens as an Uncommon Cause of Infection Following Craniectomy: A Case Report and Literature Review.Cureus · 2025Article
- Clinical and microbiological perspectives on multidrug-resistant gram-negative pathogens in bloodstream infections.International journal of critical illness and injury scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Materials and Methods: A retrospective study was conducted at a secondary-care hospital in the northern region of Oman after receiving approval from the research ethics and approval committee of Oman. The relevant data of patients diagnosed with Results: A total of 257 non-duplicate Conclusions: Our study results recommend empirical therapy with trimethoprim-sulfamethoxazole, piperacillin-tazobactam, aminoglycosides, and ciprofloxacin as first-line drugs for Serratia infection. The emergence of ESBL producers and carbapenem-resistant strains is worrisome. Regular updating of physicians' knowledge about antimicrobial profiles, antibiotic prescription policies, and infection control measures is necessary to combat antimicrobial resistance and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.